Cowen Prime Services LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cowen Prime Services LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$1,000260.0%0.00%
Q1 2018$0
-100.0%
260.0%0.00%
Q4 2017$1,000260.0%0.00%
Q2 2017$0260.0%0.00%
Q1 2017$0
-100.0%
260.0%0.00%
Q3 2016$1,0000.0%260.0%0.00%
Q2 2016$1,0000.0%260.0%0.00%
Q1 2016$1,000
-66.7%
260.0%0.00%
-100.0%
Q4 2015$3,000
-40.0%
260.0%0.00%
-50.0%
Q3 2015$5,000
-16.7%
260.0%0.00%0.0%
Q2 2015$6,000
+20.0%
260.0%0.00%0.0%
Q1 2015$5,000
+25.0%
260.0%0.00%0.0%
Q4 2014$4,000
+33.3%
260.0%0.00%
+100.0%
Q3 2014$3,0000.0%260.0%0.00%0.0%
Q2 2014$3,0000.0%260.0%0.00%0.0%
Q1 2014$3,0000.0%260.0%0.00%0.0%
Q4 2013$3,0000.0%260.0%0.00%0.0%
Q3 2013$3,000
+50.0%
260.0%0.00%0.0%
Q2 2013$2,000260.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2016
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders